Pharmaceuticals, Biotechnology and Life Sciences
PureTech Health plc has announced the appointment of immunology expert and former Genzyme group vice president, Bruce L. Roberts, Ph.D., as Chief Scientific Officer.
Georgia Healthcare Group PLC has announced that George Arveladze has been appointed as the Deputy CEO, in charge of the ambulatory and pharmaceutical businesses of the Group, with immediate effect.
Sanofi and DiCE Molecules has announced a five-year global collaboration to discover potential new therapeutics for up to 12 targets that encompass all disease areas of strategic interest to Sanofi.
FDA warns public about eye drop bottles with loose safety seals
Drug maker Valeant faces debt default risk; shares plunge 50 percent
Lilly includes a single primary endpoint of cognition (ADAS-Cog14) to EXPEDITION3 trial
Verona Pharma reports positive results from RPL554 dose-finding study
MedMined Surveillance Advisor named “the best technology for Infection Control and Monitoring”
On January 28, 2016, the United States Food and Drug Administration (FDA) approved Zepatier (elbasvir and grazoprevir) for the treatment of chronic genotype 1 or 4 hepatitis C virus (HCV) infection in adults.
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes